KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Other Accumulated Expenses (2016 - 2025)

Charles River Laboratories International has reported Other Accumulated Expenses over the past 17 years, most recently at $222.2 million for Q4 2025.

  • Quarterly results put Other Accumulated Expenses at $222.2 million for Q4 2025, up 14.51% from a year ago — trailing twelve months through Dec 2025 was $222.2 million (up 14.51% YoY), and the annual figure for FY2025 was $222.2 million, up 14.51%.
  • Other Accumulated Expenses for Q4 2025 was $222.2 million at Charles River Laboratories International, up from $216.0 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for CRL hit a ceiling of $222.2 million in Q4 2025 and a floor of $97.3 million in Q1 2021.
  • Median Other Accumulated Expenses over the past 5 years was $196.2 million (2024), compared with a mean of $184.3 million.
  • Biggest five-year swings in Other Accumulated Expenses: dropped 10.63% in 2021 and later surged 48.47% in 2022.
  • Charles River Laboratories International's Other Accumulated Expenses stood at $140.4 million in 2021, then surged by 45.67% to $204.6 million in 2022, then dropped by 0.67% to $203.2 million in 2023, then dropped by 4.53% to $194.0 million in 2024, then rose by 14.51% to $222.2 million in 2025.
  • The last three reported values for Other Accumulated Expenses were $222.2 million (Q4 2025), $216.0 million (Q3 2025), and $207.2 million (Q2 2025) per Business Quant data.